๐๐ฒ๐๐ ๐ฃ๐ฟ๐ฎ๐ฐ๐๐ถ๐ฐ๐ฒ๐ & ๐ฅ๐ฒ๐ด๐๐น๐ฎ๐๐ผ๐ฟ๐ ๐ฆ๐๐ฟ๐ฎ๐๐ฒ๐ด๐ถ๐ฒ๐ โ ๐ง๐ต๐๐ฟ๐๐ฑ๐ฎ๐ ๐ฑ๐๐ต ๐ ๐ฎ๐ฟ๐ฐ๐ต
EPiC is pleased to highlight an upcoming webinar hosted by the Research Quality Association (RQA), designed for professionals involved in clinical trial operations, IMP oversight, and regulatory compliance.
This comprehensive session will guide delegates through the full lifecycle of Investigational Medicinal Products (IMPs) , from early trial planning through to patient administration and final destruction. Participants will gain clarity on regulatory expectations, realโworld application, and how to avoid the common causes of non-compliance.
What the Webinar Will Cover
The training will explore the endโtoโend IMP journey, including:
- Protocol and Clinical Trial Authorisation (CTA) requirements
- Sourcing and managing IMP supply
- Manufacturing, packaging, and labelling considerations
- Storage, transport, and distribution obligations
- Site responsibilities: administration, accountability, and reconciliation
- IMP returns and destruction
The webinar will be delivered by two highly experienced experts, Mark Poulton and EPiC’s Operations Manager Michelle Yeomans, Former MHRA inspectors specialising in GCP and GMP, both bring extensive regulatory and industry insight that will benefit delegates at all experience levels.
Event Details
Date: Virtual, Online webinar- Thursday 5th March 2026
This session is ideal for anyone responsible for clinical trial conduct, IMP management, or quality oversight. Early booking is recommended.